Moreover, depression also results in a decrease in the level of glucocorticoid receptor (GR), leading to HPA axis disorders, while administration of antidepressant agents can reduce the peripheral level of miR-124, an upstream regulator of GR. Here, NR3C1 is linked to depressive symptom measurement.